UK refuses to back 'game-changing' resolution on drug pricing

Global agreement urges governments to share information on actual cost of medicines, with aim of making them more affordable

The UK government has refused to sign up to a global resolution on greater transparency for drug pricing.

The resolution urges governments and others buying health products to share information on actual prices paid, and pushes for greater transparency on patents, clinical trial results and other factors affecting pricing from laboratories to patients.